Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat and TSEBT in Mycosis Fungoides
NCT01187446Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Dec 2010
- Primary completion
- Aug 2013
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in mycosis fungoides (MF), sponsored by Stanford University. Started Dec 2010; status: terminated.
02
Drugs
vorinostat
03
Conditions
mycosis fungoides (MF)
Beyond the preview
Go deeper on NCT01187446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01187446.